Clinical Trials on Recurrent Squamous Cell Carcinoma of the Larynx in Germany
Total 304 results
-
AIO-Studien-gGmbHMerck Sharp & Dohme LLCNot yet recruitingSquamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Oropharynx | Squamous Cell Carcinoma of the HypopharynxGermany
-
University of Erlangen-Nürnberg Medical SchoolRecruitingSquamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Oropharynx | Squamous Cell Carcinoma of the HypopharynxGermany
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
Charite University, Berlin, GermanyCompletedSquamous Cell Carcinoma of the Neck | Squamous Cell Carcinoma of the HeadGermany
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedCarcinoma, Squamous Cell of Head and Neck | Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckGermany
-
ClinAssessSanofi; Merck Sharp & Dohme LLCCompletedSquamous Cell Carcinoma of the Hypopharynx | Larynx CarcinomaGermany, Austria
-
Institut für Klinische Krebsforschung IKF GmbH...Eli Lilly and Company; Trium Analysis Online GmbHCompletedSquamous Cell Carcinoma of the EsophagusGermany
-
University Hospital TuebingenUnknownSquamous Cell Carcinoma of the SkinGermany
-
Ulrich KeilholzCharite University, Berlin, Germany; AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckGermany
-
PCI Biotech ASTerminatedRecurrent Head and Neck Cancer | Carcinoma, Squamous Cell of Head and NeckGermany, United Kingdom, France, Lithuania, Netherlands, Poland
-
Heidelberg UniversityCompletedSinonasal Malignancies | Adenocarcinoma and Squamous Cell Carcinoma of the Paranasal SinusesGermany
-
Bristol-Myers SquibbActive, not recruiting
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Innate PharmaTerminatedSquamous Cell Carcinoma of the Oral CavityGermany, Spain
-
University Hospital TuebingenUnknownSquamous Cell Carcinoma of the Head and NeckGermany
-
Replimune Inc.Bristol-Myers SquibbWithdrawnSquamous Cell Carcinoma of Head and Neck | Recurrent Head and Neck Squamous Cell Carcinoma | Locally Advanced Head and Neck Squamous Cell CarcinomaUnited States, Spain, United Kingdom, Czechia, France, Germany, Greece, Poland
-
AstraZenecaMedImmune LLCActive, not recruitingAdvanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and NeckSpain, United States, Belgium, Germany, United Kingdom, Italy
-
Heidelberg UniversityUniversity Hospital HeidelbergTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal CancerGermany
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the Oropharynx | HPV16 PositiveNetherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
-
ISA PharmaceuticalsRegeneron PharmaceuticalsActive, not recruitingSquamous Cell Carcinoma of the OropharynxUnited States, Israel, Belgium, Germany, Spain, United Kingdom, Italy, France, Czechia
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Italy, Korea, Republic of, Spain, Greece, Germany, Japan
-
CureVacSyneos Health; Cromos Pharma LLCActive, not recruitingCarcinoma, Adenoid Cystic | Melanoma (Skin) | Squamous Cell Carcinoma of the Skin | Carcinoma, Squamous Cell of Head and NeckSpain, France, Austria, Germany, Russian Federation
-
BioNTech SERecruitingRecurrent Head and Neck Cancer | Unresectable Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck CancerGermany, United States, France, United Kingdom, Korea, Republic of, Spain, Poland, Belgium, Brazil, Taiwan, Italy, Canada, Czechia, Australia, Turkey, Mexico, Chile, Argentina, Austria, Hungary, Portugal, Sweden
-
German Cancer Research CenterUniversity Hospital TuebingenTerminatedLung Cancer Squamous CellGermany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more
-
PfizerTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, China, Taiwan, France, Australia, Hungary, Korea, Republic of, Germany, Japan, Switzerland, Ireland, Israel, United Kingdom, Italy, Poland, Belgium, Canada, Greece, Portugal, Austria, Russian Federation
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedSquamous Cell Carcinoma of the Head and NeckBrazil, Italy, United Kingdom, United States, Hong Kong, France, Netherlands, Germany, Argentina, Canada, Japan, Korea, Republic of, Spain, Switzerland, Taiwan
-
Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Squamous Cell of Head and NeckGermany
-
Charite University, Berlin, GermanyHelmholtz-Zentrum Dresden-Rossendorf; Max-Delbrück-Centrum BerlinRecruiting
-
University Hospital, EssenCompletedWindow of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN (PIONEER)Squamous Cell Carcinoma of Head and NeckGermany
-
Genentech, Inc.CompletedHead and Neck CancerUnited States, Germany, Spain, France, Australia, Hungary, Belgium, Bulgaria, United Kingdom, Italy, Romania
-
Merck KGaA, Darmstadt, GermanyCompletedHead and Neck CancerFrance, Russian Federation, Spain, United Kingdom, Germany, Hungary, Poland, Ukraine, Austria, Netherlands, Slovakia, Sweden, Switzerland, Belgium, Italy, Portugal, Czech Republic
-
Incyte Biosciences International SàrlRecruitingHead and Neck CancerUnited States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
-
Oncolytics BiotechCompletedCarcinoma, Squamous Cell of the Head and NeckUnited States, Canada, Spain, Belgium, United Kingdom, Greece, Germany, Hungary, Poland, Slovenia, France, Italy, Russian Federation
-
Incyte CorporationActive, not recruitingSquamous Cell Carcinoma of the Anal CanalUnited States, Italy, Spain, United Kingdom, Australia, France, Germany, Sweden, Japan, Norway, Belgium, Denmark, Puerto Rico
-
GlaxoSmithKlineiTeos TherapeuticsRecruitingNeoplasms, Head and NeckUnited States, Italy, Spain, Taiwan, Germany, Greece, Korea, Republic of, Romania, Sweden, Turkey, Canada, Argentina, Finland, Brazil, Japan, Poland, Portugal, France, Denmark, Hungary, Norway
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom
-
University of Erlangen-Nürnberg Medical SchoolRecruiting
-
AstraZenecaInnate PharmaActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, France, Italy, Spain, Belgium, Canada, Taiwan, Switzerland, Korea, Republic of, Japan, Poland, Russian Federation, United Kingdom, Austria, Brazil, Germany, Netherlands, Portugal, Australia, Philippines, Bulgaria, G... and more
-
Martin-Luther-Universität Halle-WittenbergUltimovacs ASA; Apotheke der Universitätsmedizin der Johannes Gutenberg-Universität... and other collaboratorsRecruitingHead and Neck Squamous Cell CarcinomaGermany
-
Technische Universität DresdenGerman Cancer Research Center; National Center for Tumor Diseases, Heidelberg; Radiation Oncology Working Group of the German Cancer Society and other collaboratorsRecruitingHead-and-neck Squamous Cell CarcinomaGermany
-
InflaRx GmbHMerck Sharp & Dohme LLCActive, not recruitingSCC - Squamous Cell Carcinoma of SkinUnited States, Spain, Germany, Belgium, France
-
Symphogen A/SCompletedCarcinoma, Squamous Cell of Head and NeckBelgium, France, Germany
-
University of Erlangen-Nürnberg Medical SchoolCompletedLocally Advanced Head and Neck Squamous Cell CarcinomaGermany
-
Technical University of MunichRecruitingHead and Neck Squamous Cell CarcinomaGermany
-
University of LeipzigRecruiting
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Canada, France, Italy, Spain, United Kingdom, Poland, Taiwan, Thailand, Vietnam, Belgium, Germany, Korea, Republic of, Brazil, India, Japan, Philippines, Russian Federation, Austria, Ukraine, Greece, Slovakia, Romania
-
Ruhr University of BochumCompletedCutaneous Squamous Cell CarcinomaGermany